And Again

When it comes to retractions, former Duke University researcher Anil Potti is the gift that keeps on giving.

As fans of scientific malfeasance no doubt recall, Potti left Duke in 2010 amidst allegations that he had manipulated data in several lung cancer biomarker studies. Duke suspended Potti (who has since taken a job at the Cancer Center of North Dakota) along with clinical trials stemming from his research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.